Latest News
Marker Therapeutics, Inc.
- Marker Therapeutics lands $2.6M FDA grant for pancreatic cancer therapy
- Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant To Advance MT-601 In Pancreatic Cancer
- Marker Therapeutics wins $2.6M FDA grant to adv...
- Marker Therapeutics receives $2.6M FDA grant for cancer study By Investing.com
- Marker Therapeutics gets $2.6M FDA grant for pancreatic cancer therapy
- Marker Therapeutics Awarded $2.6 Million FDA Orphan
- MRKR: MARKER THERAPEUTICS - Price & Consenus Chart
- Marker Therapeutics Q2 2026 Earnings: Loss Narrower Than Expected, Shares Slip - Peak Earnings Alert
Headlines from the last 30 days, linking to the original publishers. See all market news →